title: Coronary pressure measurement after stenting predicts adverse events at follow-up: a multicenter registry.
abstract: BACKGROUND
  Coronary stenting is associated with a restenosis rate of 15% to 20% at 6-month follow-up, despite optimum angiographic stent implantation. In this multicenter registry, we investigated the relation between optimum physiological stent implantation as assessed by poststent fractional flow reserve (FFR) and outcome at 6 months.
  
  
  RESULTS
  In 750 patients, coronary pressure measurement at maximum hyperemia was performed after angiographically apparently satisfactory stent implantation. Poststenting FFR was calculated and related to major adverse events (including need for repeat target vessel revascularization) at 6 months. In 76 patients (10.2%), at least 1 adverse event occurred. Five patients died, 19 experienced myocardial infarction, and 52 underwent at least 1 repeat target vessel revascularization. By multivariate analysis, FFR immediately after stenting was the most significant independent variable related to all types of events. In 36% of the patients, FFR normalized (>0.95), and event rate was 4.9% in that group. In 32% of the patients, poststent FFR was between 0.90 and 0.95, and event rate was 6.2%. In 32% of patients, poststent FFR was <0.90, and event rate was 20.3%. In 6% of the patients, FFR was <0.80, and event rate was 29.5% (P<0.001).
  
  
  CONCLUSIONS
  FFR after stenting is a strong independent predictor of outcome at 6 months.
authors.affiliation: Department of Cardiology, Catharina Hospital, Eindhoven, The Netherlands. cardiologie.catharina.zks@wxs.nl
authors.forename: Nico H J
authors.initials: NH
authors.lastname: Pijls
authors.forename: Volker
authors.initials: V
authors.lastname: Klauss
authors.forename: Uwe
authors.initials: U
authors.lastname: Siebert
authors.forename: Eric
authors.initials: E
authors.lastname: Powers
authors.forename: Kenji
authors.initials: K
authors.lastname: Takazawa
authors.forename: William F
authors.initials: WF
authors.lastname: Fearon
authors.forename: Javier
authors.initials: J
authors.lastname: Escaned
authors.forename: Yukio
authors.initials: Y
authors.lastname: Tsurumi
authors.forename: Takashi
authors.initials: T
authors.lastname: Akasaka
authors.forename: Habib
authors.initials: H
authors.lastname: Samady
authors.forename: Bernard
authors.initials: B
authors.lastname: De Bruyne
mesh_terms: D001794:Blood Pressure; D003326:Coronary Circulation; D023903:Coronary Restenosis / Q000209:etiology / Q000503:physiopathology*; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D012042:Registries; D015607:Stents / Q000009:adverse effects*; D016896:Treatment Outcome